Publications en collaboration avec des chercheurs de Universidad Complutense de Madrid (14)

2025

  1. Copper-mediated divergent reactivity of allene-tethered carbamates under radical conditions

    Organic Letters, Vol. 27, Núm. 25, pp. 6823-6829

  2. N-Methyl-N-((1-methyl-5-(3-(piperidin-1-yl)propoxy)-1H-benzo[d]imidazol-2-yl)methyl)prop-2-yn-1-amine (MBA-159), a new multitarget small molecule for the therapy of Alzheimer's disease

    Biomedicine and Pharmacotherapy, Vol. 192

2024

  1. Ni(2,2′:6′,2′′-terpyridine)2: a high-spin octahedral formal Ni(0) complex

    Dalton Transactions, Vol. 53, Núm. 20, pp. 8550-8554

2023

  1. Straightforward Synthesis of Bis[(trifluoromethyl)sulfonyl]ethylated Isocoumarins from 2-Ethynylbenzoates

    Journal of Organic Chemistry, Vol. 88, Núm. 11, pp. 7373-7380

2022

  1. Superparamagnetic Iron Oxide Nanoparticles Decorated Mesoporous Silica Nanosystem for Combined Antibiofilm Therapy

    Pharmaceutics, Vol. 14, Núm. 1

2021

  1. Emerging Strategies in Anticancer Combination Therapy Employing Silica-Based Nanosystems

    Biotechnology Journal, Vol. 16, Núm. 3

  2. Pd-catalyzed C(sp3)-C(sp) bond formation in iodocyclobutenes

    Chemical Communications, Vol. 57, Núm. 68, pp. 8456-8459

  3. Recent advances toward the use of mesoporous silica nanoparticles for the treatment of bacterial infections

    International Journal of Nanomedicine, Vol. 16, pp. 4409-4430

2020

  1. Homo-tris-nitrones derived from α-phenyl-n-tert-butylnitrone: Synthesis, neuroprotection and antioxidant properties

    International Journal of Molecular Sciences, Vol. 21, Núm. 21, pp. 1-18

  2. In Vitro and in Silico ADME-Tox Profiling and Safety Significance of Multifunctional Monoamine Oxidase Inhibitors Targeting Neurodegenerative Diseases

    ACS Chemical Neuroscience, Vol. 11, Núm. 22, pp. 3793-3801

  3. Synthesis, antioxidant properties and neuroprotection of α-phenyl-tert-butylnitrone derived HomoBisNitrones in in vitro and in vivo ischemia models

    Scientific Reports, Vol. 10, Núm. 1

2019

  1. Donepezil + chromone + melatonin hybrids as promising agents for Alzheimer’s disease therapy

    Journal of Enzyme Inhibition and Medicinal Chemistry, Vol. 34, Núm. 1, pp. 479-489

  2. Quinoxalinetacrine QT78, a cholinesterase inhibitor as a potential ligand for Alzheimer’s disease therapy

    Molecules, Vol. 24, Núm. 8

  3. Synthesis, neuroprotective and antioxidant capacity of PBN-related indanonitrones

    Bioorganic Chemistry, Vol. 86, pp. 445-451